H.I.G. Capital Recapitalizes Navitas Life Sciences
September 13, 2022
An affiliate of H.I.G. Capital completed the recapitalization of Navitas Life Sciences, a Princeton, New Jersey–based technology-enabled clinical research organization (CRO). The transaction follows H.I.G.'s earlier agreement to acquire a majority (~75%) stake from TAKE Solutions and will provide Navitas with capital and resources to accelerate growth and expand its technology-enabled CRO capabilities.
- Buyers
- H.I.G. Capital
- Targets
- Navitas Life Sciences
- Sellers
- TAKE Solutions Limited
- Industry
- Healthcare Services
- Location
- New Jersey, United States
- Transaction Type
- Recapitalization
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.